The Synaptic Bases of Mental Diseases
15 March 2019
EPFL spinoffs Lumendo and GliaPharm are among 80 deep-tech startups from around the world that have qualified for the finals of the Hello Tomorrow Challenge in Paris tomorrow. The finalists will pitch their company to a jury of technology specialists Read more…
5 May 2017
C. Finsterwald, A. Magistretti, P. Magistretti, S. Lengacher GliaPharm, tackling Stephen Hawking’s disease, moves to Campus Biotech, Geneva. There are approximately 800 people working in the Campus Biotech building, say its promoteurs. However, some floors of the Lemanic pole dedicated Read more…
